Evaluation of the Pathobiology of CALR-mutated MPN Cells
Evaluation of the Pathobiology of CALR-mutated MPN Cells
Recruiting · NCT06480591 · Registry updated 2026-07-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of the Pathobiology of CALR-mutated MPN Cells | Embolism and Thrombosis, Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, cardiovascular disorder, hematologic disorder, myeloproliferative neoplasm, thrombotic disease, vascular disorder | Recruiting | Not stated | 2026-07-13 | NCT06480591 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Atrium Health Levine Cancer Institute | 27 |
| Brookdale University Hospital Medical Center | 1 |
| Wake Forest University Health Sciences | 284 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Atrium Health Levine Cancer | Charlotte | United States | 13 |
| Wake Forest Baptist Comprehensive Cancer Center | Winston-Salem | United States | 26 |